Literature DB >> 16750574

Altered subcellular signaling in murine peritoneal macrophages upon chronic morphine exposure.

Ana M Lugo-Chinchilla1, Dennise Báez, Mariella Vélez, Cristhian Ildefonso, Fernando L Renaud.   

Abstract

Alterations in opioid signaling that take place in murine peritoneal macrophages in vitro are variably dependent on opiate exposure conditions. Acute exposure to morphine inhibits Fc-mediated phagocytosis by a pertussis toxin (PT)-sensitive mechanism, but has no effect on cAMP levels. In contrast, chronic exposure to morphine results in a "tolerant" state, wherein test and control values for both phagocytosis and cAMP are equivalent. However, drug withdrawal after chronic exposure to morphine results in inhibition of phagocytosis and a concomitant 4-fold increase in cAMP by a PT-insensitive mechanism. This increase is causally related to inhibition of phagocytosis since an artificial increase in cAMP inhibits phagocytosis in non-withdrawn cells exposed chronically to morphine. We suggest that macrophage opioid receptors signaling switches from a Gi/o-mediated mechanism that does not involve adenylate cyclase in acute exposure to a non-Gi/o-mediated adenylate cyclase superactivation during chronic exposure.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16750574     DOI: 10.1016/j.jneuroim.2006.04.007

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

Review 1.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 2.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

Review 3.  Opioid drug abuse and modulation of immune function: consequences in the susceptibility to opportunistic infections.

Authors:  Sabita Roy; Jana Ninkovic; Santanu Banerjee; Richard Gene Charboneau; Subhas Das; Raini Dutta; Varvara A Kirchner; Lisa Koodie; Jing Ma; Jingjing Meng; Roderick A Barke
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-26       Impact factor: 4.147

Review 4.  Role of the mu-opioid receptor in opioid modulation of immune function.

Authors:  Jana Ninković; Sabita Roy
Journal:  Amino Acids       Date:  2011-12-15       Impact factor: 3.520

5.  Anti-CD40 antibody and toll-like receptor 3 ligand restore dendritic cell-mediated anti-tumor immunity suppressed by morphine.

Authors:  Ming-Cheng Chang; Yu-Li Chen; Ying-Cheng Chiang; Ya-Jung Cheng; Yu-Wei Jen; Chi-An Chen; Wen-Fang Cheng; Wei-Zen Sun
Journal:  Am J Cancer Res       Date:  2016-01-15       Impact factor: 6.166

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.